Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-904X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug ; day:17 ; month:1 ; year:2017 ; pages:1-8
Pharmaceutical research ; (17.1.2017), 1-8
- Keyword
-
Arzneimittelentwicklung
Arzneimitteldesign
- Creator
-
Leal, Leila Bastos
- Contributor
-
Cordery, Sarah F.
Delgado-Charro, M. Begoña
Bunge, Annette L.
Guy, Richard H.
SpringerLink (Online service)
- DOI
-
10.1007/s11095-017-2099-1
- URN
-
urn:nbn:de:1111-201702141441
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leal, Leila Bastos
- Cordery, Sarah F.
- Delgado-Charro, M. Begoña
- Bunge, Annette L.
- Guy, Richard H.
- SpringerLink (Online service)
Other Objects (12)
New approaches for antifungal drugs
Hospital use of systemic antifungal drugs
Advanced Vesicular Systems for Antifungal Drug Delivery
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
Review of the novel antifungal drug olorofim (F901318)
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp
Nanogels as Antifungal‐Drug Delivery System Against Aspergillus Fumigatus
Correction: Review of the novel antifungal drug olorofim (F901318)
Current applications and prospects of nanoparticles for antifungal drug delivery
In vitro release testing as an alternative to establishing bioequivalence of drug products in vivo
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Development of enabling methodologies for drug metabolism studies in zebrafish larvae
New approaches for antifungal drugs
Hospital use of systemic antifungal drugs
Advanced Vesicular Systems for Antifungal Drug Delivery
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
Review of the novel antifungal drug olorofim (F901318)
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp
Nanogels as Antifungal‐Drug Delivery System Against Aspergillus Fumigatus
Correction: Review of the novel antifungal drug olorofim (F901318)
Current applications and prospects of nanoparticles for antifungal drug delivery
In vitro release testing as an alternative to establishing bioequivalence of drug products in vivo
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Development of enabling methodologies for drug metabolism studies in zebrafish larvae
New approaches for antifungal drugs
Hospital use of systemic antifungal drugs
Advanced Vesicular Systems for Antifungal Drug Delivery
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
Review of the novel antifungal drug olorofim (F901318)
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp
Nanogels as Antifungal‐Drug Delivery System Against Aspergillus Fumigatus
Correction: Review of the novel antifungal drug olorofim (F901318)
Current applications and prospects of nanoparticles for antifungal drug delivery
In vitro release testing as an alternative to establishing bioequivalence of drug products in vivo
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients